IVUS guidance bests angiography guidance in PCI for acute coronary syndrome healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Ticagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial.
A sham-controlled trial in this progressive, often debilitating disease showed patients treated with a radiofrequency device had longer 6-minute walk times and other benefits.